CN105754893B - Nano silver particles for aquatic products, preparation and application thereof, and bacillus subtilis strain - Google Patents
Nano silver particles for aquatic products, preparation and application thereof, and bacillus subtilis strain Download PDFInfo
- Publication number
- CN105754893B CN105754893B CN201610081986.9A CN201610081986A CN105754893B CN 105754893 B CN105754893 B CN 105754893B CN 201610081986 A CN201610081986 A CN 201610081986A CN 105754893 B CN105754893 B CN 105754893B
- Authority
- CN
- China
- Prior art keywords
- bacillus subtilis
- silver
- silver particles
- silver nanoparticles
- nano silver
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 235000014469 Bacillus subtilis Nutrition 0.000 title claims abstract description 39
- 244000063299 Bacillus subtilis Species 0.000 title claims abstract description 37
- 239000002245 particle Substances 0.000 title claims abstract description 16
- 238000002360 preparation method Methods 0.000 title abstract description 8
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 title description 21
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 claims abstract description 49
- 241000238557 Decapoda Species 0.000 claims abstract description 27
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000000243 solution Substances 0.000 claims abstract description 24
- 238000000034 method Methods 0.000 claims abstract description 11
- 239000000047 product Substances 0.000 claims abstract description 11
- 239000006228 supernatant Substances 0.000 claims abstract description 11
- 241000607272 Vibrio parahaemolyticus Species 0.000 claims abstract description 7
- 208000015181 infectious disease Diseases 0.000 claims abstract description 7
- 239000011259 mixed solution Substances 0.000 claims abstract description 7
- 238000005286 illumination Methods 0.000 claims abstract description 4
- 229910001961 silver nitrate Inorganic materials 0.000 claims abstract description 4
- 238000001914 filtration Methods 0.000 claims abstract description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract 2
- 241000238553 Litopenaeus vannamei Species 0.000 claims description 16
- 238000009360 aquaculture Methods 0.000 claims description 11
- 244000144974 aquaculture Species 0.000 claims description 11
- 238000004321 preservation Methods 0.000 claims description 9
- 101710134784 Agnoprotein Proteins 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 239000001963 growth medium Substances 0.000 claims description 6
- 210000001035 gastrointestinal tract Anatomy 0.000 claims description 4
- 238000011534 incubation Methods 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 2
- 241000894006 Bacteria Species 0.000 abstract description 9
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 7
- 239000003242 anti bacterial agent Substances 0.000 abstract description 4
- 239000004480 active ingredient Substances 0.000 abstract description 2
- 229940088710 antibiotic agent Drugs 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 230000001954 sterilising effect Effects 0.000 abstract 1
- 238000002474 experimental method Methods 0.000 description 19
- 230000004083 survival effect Effects 0.000 description 17
- 229910052709 silver Inorganic materials 0.000 description 13
- 239000004332 silver Substances 0.000 description 13
- 239000002105 nanoparticle Substances 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 206010047400 Vibrio infections Diseases 0.000 description 8
- 239000000843 powder Substances 0.000 description 7
- 108020004465 16S ribosomal RNA Proteins 0.000 description 6
- 108010010803 Gelatin Proteins 0.000 description 6
- 241000607598 Vibrio Species 0.000 description 6
- 239000008273 gelatin Substances 0.000 description 6
- 229920000159 gelatin Polymers 0.000 description 6
- 235000019322 gelatine Nutrition 0.000 description 6
- 235000011852 gelatine desserts Nutrition 0.000 description 6
- 239000013641 positive control Substances 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 230000000845 anti-microbial effect Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000013642 negative control Substances 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 239000006041 probiotic Substances 0.000 description 4
- 235000018291 probiotics Nutrition 0.000 description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- 241000607618 Vibrio harveyi Species 0.000 description 3
- 238000002441 X-ray diffraction Methods 0.000 description 3
- 238000000862 absorption spectrum Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 230000002354 daily effect Effects 0.000 description 3
- 238000009313 farming Methods 0.000 description 3
- 235000014102 seafood Nutrition 0.000 description 3
- 229940100890 silver compound Drugs 0.000 description 3
- 150000003379 silver compounds Chemical class 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 230000004584 weight gain Effects 0.000 description 3
- 235000019786 weight gain Nutrition 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 239000012228 culture supernatant Substances 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 238000009629 microbiological culture Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 230000000529 probiotic effect Effects 0.000 description 2
- 238000006722 reduction reaction Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000035806 respiratory chain Effects 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241000195576 Bacillus subtilis group Species 0.000 description 1
- 108020000946 Bacterial DNA Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- 229910017488 Cu K Inorganic materials 0.000 description 1
- 229910017541 Cu-K Inorganic materials 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- -1 Silver ions Chemical class 0.000 description 1
- 238000003917 TEM image Methods 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000002306 biochemical method Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000001632 homeopathic effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000037230 mobility Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 244000039328 opportunistic pathogen Species 0.000 description 1
- 230000010627 oxidative phosphorylation Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000000243 photosynthetic effect Effects 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000004627 transmission electron microscopy Methods 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/07—Bacillus
- C12R2001/125—Bacillus subtilis ; Hay bacillus; Grass bacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P3/00—Preparation of elements or inorganic compounds except carbon dioxide
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention relates to a preparation method of nano silver particles for aquatic products and application thereof in resisting vibrio parahaemolyticus infection of prawns, and the invention is that bacillus subtilis is mixed with a silver nitrate solution for filtration sterilization in a supernatant of a culture solution; oscillating and incubating the mixed solution at room temperature under the condition of illumination to obtain silver nanoparticles, wherein the obtained 1. the silver nanoparticles have better antibacterial activity; 2. the harm to the environment caused by excessive use of antibiotics is avoided; 3. the nano silver particles prepared by the method contain the active ingredients of the supernatant of the bacillus subtilis, so the nano silver particles can play a role in promoting growth while resisting bacteria.
Description
Technical Field
The invention relates to a nano silver particle for aquatic products, preparation and application thereof, and a bacillus subtilis strain.
Background
The united nations food and agriculture organization estimates that the amount of wild resources has dropped due to over-fishing and that by 2020, half of the world's demand for seafood will depend on the supply of aquaculture (morirty, 1999). Shrimp culture is widely distributed all over the world and develops rapidly. From 2000 to 2012, shrimp culture yield increased more than two times. Recent studies have shown that by 2050, the yield of aquatic products at least needs to be turned over again to meet the ever-increasing demand of people (Richard Waite, 2014).
Aquaculture plays an important role in the world economy. In 2004, aquaculture production accounted for 1/3 (32.4%) of the total world seafood production (FAO, 2007). In developed countries, the yield of aquatic products increases at an average rate of 3.9% per year; in developing countries, the annual growth rate of aquatic product production is 8.2% (FAO, 2007). Today about 47% of seafood comes from aquaculture (FAO, 2009; 2010). Litopenaeus vannamei is one of the world's important economic species for aquaculture (FAO, 2012). The shrimp was originally produced in the east pacific and introduced into china in the 80's of the 20 th century (FAO, 2009; 2010). By 2010, the yield of the litopenaeus vannamei accounts for 85 percent of the total yield of the shrimps in China, and becomes the most main shrimp breeding variety in China. According to fishery data of the food and agriculture organization of the united nations in 2006, the shrimp species have been widely cultivated in south asia, north africa and south africa. The total yield of world Litopenaeus vannamei farming has increased from less than 10,000 tons in 1970 to 3,000,000 tons in 2011 (Li and Xiaoing 2013; Barbazuk et al, 2007).
However, with the development of commercial prawn farming, epidemic diseases caused by opportunistic pathogens such as viruses, bacteria and fungi have also become more severe (Lightner, 1985). Vibriosis is a main disease which troubles aquatic organisms, particularly shrimps, all the year round; gastroenteritis can be caused by eating marine product with vibriosis. The chief culprit responsible for vibriosis is the bacteria of the Vibrio genus Vibrio. The bacteria are widely distributed in estuaries and oceans, and the prevention of vibriosis becomes a main challenge facing aquaculture.
Probiotics are living microbial cells that can serve as a bait additive, playing a health-improving role. Photosynthetic bacteria, yeasts, bacilli and lactobacilli have been tested and evaluated for use as probiotics in fish, shellfish and crustacean farming. Among them, Bacillus is now widely used as an effective probiotic because it secretes a range of extracellular enzymes and antimicrobial compounds (Moriarty, 1996; 1998).
Vibriosis caused by the intensive aquaculture mode causes huge loss. While biosynthetic silver nanoparticles (AgNPs) are potential antimicrobial agents; the application of the silver nanoparticles is expected to become an effective method for preventing and controlling pathogens.
Silver compounds have long been used to control microbial proliferation. In an in vitro environment, silver nanoparticles have proven to have utility against fungi and bacteria, even antibiotic-resistant bacteria (Wright et al, 1994,1999). Silver nanoparticles have also been used in the fields of biological research such as drug presentation, wound treatment, and the like. Silver ions and silver compounds are known to be highly toxic to microorganisms (Slawson et al, 1992) and are therefore used as antibacterial compounds. Silver compounds are now commonly used in industrial and sanitary applications, such as packaging catheters and surgical materials, manufacturing synthetic compounds for dental applications, homeopathic applications, water purification, etc.
Silver exerts antimicrobial activity by different mechanisms. Silver is reported to decouple the electron-transporting respiratory chain from oxidative phosphorylation and to inhibit enzymes in the respiratory chain (Schreurs & Roseberg 1982; Bard & Holt 2005). Yoon et al (2007) observed that silver nanoparticles have a stronger resistance to Bacillus subtilis than to Escherichia coli, suggesting selectivity in their antimicrobial activity; this selectivity may be related to the structure of the bacterial cell membrane. In view of this, the present study used probiotic bacillus to prepare silver nanoparticles as antibacterial agents; and the efficacy of the antibacterial agent in preventing and controlling vibriosis in shrimp culture is tested by taking litopenaeus vannamei as an experimental animal.
Disclosure of Invention
Aiming at the defects in the prior art, the invention aims to solve the technical problem that
The technical scheme adopted by the invention for realizing the purpose is as follows: a preparation method of nano silver particles for aquatic products and application of the nano silver particles in resisting vibrio parahaemolyticus infection of prawns are provided.
The classification names are: the Bacillus subtilis and the Bacillus subtilis have the following preservation numbers: CGMCC No. 11452; the preservation date is as follows: 09 month and 23 days 2015; the preservation unit: china general microbiological culture Collection center.
Bacillus subtilis in the supernatant of the culture and silver nitrate (AgNO) sterilized by filtration3) Mixing the solutions; and oscillating and incubating the mixed solution at 200rpm for 24-26 h under the conditions of room temperature and illumination to obtain the silver nanoparticles.
AgNO obtained after mixing of the solution3The final concentration was 1 mM.
The bacillus subtilis is put in a conical flask filled with LB culture medium, the shaking culture is carried out for 48 h-52 h at the room temperature of 200rpm, and the culture solution is centrifuged for 10min at 12,000rpm to obtain supernatant.
The mixture is incubated under light or shaking at room temperature.
The invention has the following advantages and beneficial effects:
1. the nano silver particles have better antibacterial activity
2. Avoids the harm to the environment caused by excessive use of antibiotics
3. The nano silver particles prepared by the method contain the active ingredients of the supernatant of the bacillus subtilis, so the nano silver particles can play a role in promoting growth while resisting bacteria.
Drawings
FIG. 1 is a graph showing the results of mixing a supernatant of a Bacillus subtilis culture medium with AgNO3 solution (left) and a control culture medium without AgNO3 (right);
FIG. 2 is a graph showing that the molecular weight of purified protein in a silver nanoparticle solution is about 55kDa by 10% SDS-polyacrylamide gel electrophoresis;
FIG. 3 is a graph of the optical characteristics of a sample of silver nanoparticles in the wavelength range of 300-700nm as analyzed by UV-Vis spectrophotometer;
FIG. 4 is a transmission electron micrograph of silver nanoparticles prepared using Bacillus subtilis; (a) is one of the silver nanoparticles; (b) preparing silver nanoparticles with different sizes;
FIG. 5 is a graph showing the results of nano-silver particles prepared using X-ray diffraction pattern analysis;
FIG. 6 shows the survival rate of each group of litopenaeus vannamei in the vibrio infection experiment. (PBS), negative control group injected with PBS. (AgNPs), silver nanoparticle group was fed. (B.subtilis), feeding the Bacillus subtilis group. (Control) Vibrio was injected alone, and the positive Control group was not fed with any additional component. The final survival was expressed as mean ± sd for 3 replicates per group.
Detailed Description
Example 1
1. Materials and methods
Isolation and characterization of Bacillus subtilis strains
The bacillus subtilis strain for preparing the silver particles is separated from the intestinal tract of the litopenaeus vannamei. The details are as follows. The litopenaeus vannamei used was bred in this laboratory. After the litopenaeus vannamei opens the stomach for 24 hours, dissecting out an intestinal tract, diluting the homogenate in a gradient manner, coating the diluted homogenate on an LB plate culture medium, and culturing the diluted homogenate for 24 hours at 37 ℃. The grown clones were verified by biochemical methods using Bergey' S manual for systematic bacteriology and finally confirmed by their 16S rDNA sequences.
Molecular identification
The isolated strain was identified by analyzing its 16S rDNA sequence. The DNA of the strain was extracted using a bacterial DNA extraction kit (tiaram, cat. No. dp302), quality checked by agarose gel electrophoresis, and further quantified using a spectrophotometer NanoQuant (Infinite M200 PRO). The 16S rDNA sequence of the strain was amplified using the extracted DNA as a template, using primers 27-F (5'-AGA GTT TGA TCC TGG CTC AG-3') and 1492-R (5'-TAC CTT GTT ACG ACT T-3'). The total volume of the PCR reaction system was 50. mu.l: mu.l of template, 5.0. mu.l of 10 Xbuffer, 1. mu.l of dNTP (10mM), 1.5. mu.l of forward and reverse primers (10. mu.M)), 1.0. mu.l of Ex Taq DNA polymerase (5U/. mu.l, TAKARA, Japan) and 39.0. mu.l of ultrapure water. The PCR procedure was as follows: pre-denaturation at 95 ℃ for 5 min; denaturation at 95 ℃ for 30s, annealing at 55 ℃ for 45s, and extension at 72 ℃ for 1.5min, and repeating the process for 45 cycles; finally, extension was carried out at 72 ℃ for 7 min. The PCR products were detected using 1% agarose and then sequenced. And (3) aligning and identifying the sequence obtained by sequencing in a GenBank database.
The molecular weight of the proteins in the silver nanoparticle solution was estimated by comparing the relative mobilities of different molecular weight proteins using 10% SDS-polyacrylamide gel electrophoresis according to a standard protein molecular weight Marker.
Preparation of silver nanoparticles
Bacillus subtilis was cultured in a 250-mL Erlenmeyer flask containing 100mL of sterilized broth at 200rpm for 48h with shaking at room temperature (25 ℃). Centrifuging the culture solution at 12,000rpm for 10min to obtain supernatant and filter sterilized silver nitrate (AgNO)3) Solution mixing (AgNO)3 Final concentration 1 mM). And (3) incubating the mixed solution for 24h under the conditions of room temperature and illumination and shaking at 200rpm, and preparing the silver nanoparticles extracellularly. Monitoring anion reduction by optical observationThereby forming a nanoparticle.
Silver nanoparticle identification
The optical characteristics of the prepared silver nanoparticles were analyzed by measuring the absorbance of the silver nanoparticle sample using an ultraviolet-visible spectrophotometer (Hitachi U5100) in the wavelength range of 300-700nm by transmission electron microscopy analysis using a carbon film copper mesh, the shape and size of the prepared silver nanoparticles were observed by dropping the silver nanoparticle sample on the copper mesh, staying for 2 minutes, then sucking off the excess liquid, air-drying and fixing the copper mesh, then measuring and recording the morphological data of the silver nanoparticles using a transmission electron microscope (JEOL-JEM-1200EX), supernatant-cooling and freeze-drying the culture solution containing the silver nanoparticles, and XRD analysis using Cu-K α in a powder diffractometer (ULTIMA IV model, Rigaku) with an instrument operating voltage of 400kV and 40 mA.
Analysis of antibacterial Activity of silver nanoparticles
Antimicrobial activity of the prepared silver nanoparticles was determined using filter paper plate diffusion comparative analysis (Casida, 1986). The vibrio parahaemolyticus and the vibrio harveyi are cultured in a meat soup culture medium for 24 hours at 37 ℃. The culture was spread on MH agar plates using sterilized cotton swabs. 50 μ L of silver nanoparticles were mixed with 1mL of sterile water and applied to a 5mm diameter sterile filter paper sheet. Bacillus subtilis (50. mu.L) was also treated in the same manner and tested for antimicrobial activity. A sterilized filter paper sheet without any treatment was used as a control. The plates were incubated overnight at 37 ℃ and the formation of zones of inhibition was observed.
Litopenaeus vannamei breeding and in vivo antibacterial activity research
Litopenaeus vannamei (average weight 6.82. + -. 2.16g) from south Hainan Biotechnology Ltd was used for the experiments. Before the experiment, the experimental shrimps are cultured in a 50L rectangular water tank to adapt for 3 days. The physical and chemical parameters of salinity, temperature, pH and the like of the aquaculture water body are regularly monitored, and a suitable aquaculture environment is maintained by changing water.
And (3) selecting healthy Litopenaeus vannamei to test the antibacterial effect of the prepared silver nanoparticles in the prawn body. For this purpose, 4 experimental groups and 1 control group were set, with 20 shrimps per group; the experimental group and the control group are provided withSet 3 replicates. The control group of shrimps were fed with the conventional diet only. Experiment group I was fed with conventional bait, plain gelatin powder and Bacillus subtilis (10)5cfu/ml-1). Experiment group II was fed with regular bait and the original gelatin powder, and 0.1mg of the prepared silver nanoparticles was added per 10mg of the regular bait. The experiment group III is fed with conventional bait and original gelatin powder, and 0.1mg of silver ion solution is added into each 10mg of conventional bait. Experiment group IV feeds conventional bait and original gelatin powder, and 10mg of the bait is added into each 10mg of the conventional bait6CFU/mL Vibrio.
Prior to the experiment, all the shrimps were starved for 1 day. The entire experiment lasted 64 days. Feeding at 8:00 and 20:00 every day, siphoning out the residual bait in the aquaculture water body before feeding, and changing water once every three days, wherein the water changing amount is about 50 percent. Shrimp survival was recorded daily.
Survival and growth Rate analysis
The final weight, survival rate, weight gain, Feed Conversion Rate (FCR) and Specific Growth Rate (SGR) of the shrimp were determined at the end of the experiment according to the methods described by Robertson et al (2000), Felix and Sudharsan (2004) and zokeafilar et al (2012).
Gain (g/shrimp) final weight (g) -initial weight (g)
Bait conversion rate (FCR) total feed amount (g)/weight gain (g)
Specific growth rate (SGR,%/day) [ (final weight-initial weight)/day ] × 100
Infection experiments
The Vibrio parahaemolyticus infection experiment lasted for 15 days. Vibrio parahaemolyticus was grown overnight in 2216E medium and its concentration was adjusted to 106CFU/mL. The experiment was set up with 2 experimental groups (designated treatment I and treatment II groups, respectively) and 2 control groups (positive and negative control groups). Each group of 10 shrimps was cultured in a 30L water tank. Each set was set with 3 replicates. The experimental group and the positive control group were each injected with 20. mu.L of Vibrio parahaemolyticus suspension from the last abdominal node, and the negative control group was each injected with 20. mu.L of PBS solution. The experimental shrimps were monitored daily for mortality. After the experiment, the transcription level of the immune related gene of the survival shrimp is checked. Treating group I feeding original flavor gelatin powder and preparedSilver nanoparticles. And the treatment group II feeds the original gelatin powder and the bacillus subtilis. Both the positive control group and the negative control group were fed with standard bait only. The death of each group was observed and recorded daily during the experiment. After the experiment is finished, the shrimps in the experimental group and the shrimps in the positive control group are used for RNA extraction, and the relative expression quantity of the immune genes is analyzed.
Results of the experiment
Isolation and identification of strains synthesizing silver nanoparticles
7 strains which can possibly synthesize silver nanoparticles are separated from intestinal tracts of litopenaeus vannamei. According to the biochemical characteristics of the strains, 1 strain is selected for the subsequent preparation of silver nanoparticles. BLAST comparison of the obtained 16S rRNA gene sequences of the candidate strains in NCBI database revealed that they have 100% similarity to the 16S rRNA gene sequence of Bacillus subtilis (J812207). Therefore, the 16S rRNA gene sequences of the obtained candidate strains were named B.subtilis 1725505EJ1(Accession number: J812207) and submitted to GenBank.
Bacillus subtilis strain, classified name: the Bacillus subtilis and the Bacillus subtilis have the following preservation numbers: CGMCC No. 11452; the preservation date is as follows: 09 month and 23 days 2015; the preservation unit: china general microbiological culture Collection center.
Preparation of silver nanoparticles
Culture supernatant of Bacillus subtilis and AgNO3And mixing and incubating the solution. With the increase of the incubation time, the color of the mixed solution is gradually deepened to brown yellow; control medium did not contain AgNO3No color change (left in fig. 1). 24 hours after the incubation, the culture solution supernatant of the bacillus subtilis and AgNO3The mixture of solutions appeared brown (fig. 1 right). SDS-polyacrylamide gel electrophoresis showed that the purified protein from the silver nanoparticle solution had a molecular weight of about 55kDa (FIG. 2).
Characterization of silver nanoparticles
The optical characteristics of the silver nanoparticle samples were analyzed using a uv-vis spectrophotometer in the wavelength range 300-. The silver nanoparticles are excited by surface plasmon polaritons in ultravioletThe absorption spectrum has strong absorption peaks. According to the observation, the prepared sample has an absorption peak at a wavelength of 420nm, showing that silver nanoparticles are successfully formed (fig. 3). This absorption spectrum was measured on the Bacillus subtilis culture supernatant and AgNO3The solution can be generated within 24 hours after mixing. The color change of the mixed solution and the absorption spectrum analysis result prove that the AgNO is added under the action of the culture solution supernatant3A reduction reaction occurs to form silver nanoparticles. To further confirm the formation of silver nanoparticles, the mixed solution sample was observed using a transmission electron microscope. The electron microscopy data show that the silver nanoparticles are of different sizes, most of the silver nanoparticles are spherical, and the diameter of the silver nanoparticles is 10-25nm (figure 4). To further determine the properties of the prepared silver nanoparticles, their X-ray diffraction patterns were analyzed (fig. 5).
Detection of antibacterial activity of silver nanoparticles
Determination and comparison of silver nanoparticles, Bacillus subtilis, and AgNO using filter paper plate diffusion3anti-Vibrio parahaemolyticus and Vibrio harveyi activity. The results show that the silver nanoparticles remarkably inhibit the growth of two vibrios, and the diameters of inhibition zones are 21.25 +/-2.55 mm and 19.27 +/-1.36 mm respectively. The diameters of inhibition zones generated by the bacillus subtilis for resisting the two bacteria are respectively 12.65 +/-1.71 and 13.29 +/-1.58 mm. This indicates that the silver nanoparticles have a stronger vibrio inhibitory activity than bacillus subtilis. AgNO3The solution produced a zone of inhibition of less than 1mm while the control did not show any bacteriostatic activity.
Growth and survival of Litopenaeus vannamei
In order to compare the growth and survival conditions of the litopenaeus vannamei fed with different baits, the initial weight, the final weight, the weight gain, the specific growth rate, the bait conversion rate and the survival rate of the litopenaeus vannamei are measured.
There was no significant difference in initial body weight between the control and experimental groups (P > 0.05). The yield of the experimental group II is the highest and is 9.364 +/-0.019 g, while the yield of the control group is 6.33 +/-0.01 g, and the difference of the yields of the two groups is obvious (P < 0.05). The yields of the experimental group I, the experimental group III and the experimental group IV are respectively 7.19 +/-0.01, 3.90 +/-0.04 and 3.04 +/-0.04 g, and the yields are also significantly different from those of the control group (P <0.05), but the yields are all lower than those of the experimental group II. Similarly, the specific growth rate of the experimental group II was also highest in each group. Also, the experimental group II showed better conversion rate of bait (0.7. + -. 0.014) compared with the other groups. The monitoring of the survival condition of the prawns shows that the survival rate of the experimental group I is 89.2 +/-0.88, and the survival rate of the experimental group II is 100 +/-00%; the survival rate of the control group was only 83.8 + -1.42%, while the survival rates of the experimental groups III and IV were lower, 40.6 + -1.2 and 25.1 + -0.5, respectively.
Survival in infection experiments and expression of immune-related genes
The final survival information for each group of infection experiments is shown in FIG. 6. Injection of high dose Vibrio harveyi (10)6CFU/mouse), the survival rate of the silver nanoparticle-fed group was the highest (85.5 ± 0.5%), which was significantly higher than that of the bacillus subtilis-fed group (65.6 ± 0.57%) and the vibrio-injection-only positive control group (11.6 ± 0.32%) (P)<0.05) (fig. 6). The negative control group injected with PBS had no shrimp dead.
Claims (5)
1. A method for preparing nano silver particles for aquatic products by using bacillus subtilis strains is characterized by comprising the following steps: supernatant of Bacillus subtilis culture solution and silver nitrate (AgNO) for filtration sterilization3) Mixing the solutions; the mixed solution is subjected to shaking incubation for 24-26 h at 200rpm under the conditions of room temperature and illumination to obtain silver nanoparticles, and the bacillus subtilis strain is characterized in that: the classification names are: the Bacillus subtilis and the Bacillus subtilis have the following preservation numbers: CGMCC No. 11452; the preservation date is as follows: 09 month and 23 days 2015; the preservation unit: the bacillus subtilis strain is separated from the intestinal tract of the litopenaeus vannamei.
2. A method according to claim 1, characterized in that:
AgNO obtained after mixing of the solution3The final concentration was 1 mM.
3. A method according to claim 1, characterized in that: and (3) placing the bacillus subtilis in a conical flask filled with LB culture medium, carrying out shaking culture at 200rpm at room temperature for 48-52 h, and centrifuging the culture solution at 12,000rpm for 10min to obtain a supernatant.
4. An aquaculture nano-silver particle prepared by the method of any one of claims 1 to 3.
5. An application of the nano silver particles for aquatic products in preparing a medicament for resisting vibrio parahaemolyticus infection of prawns, according to claim 4.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610081986.9A CN105754893B (en) | 2016-02-05 | 2016-02-05 | Nano silver particles for aquatic products, preparation and application thereof, and bacillus subtilis strain |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610081986.9A CN105754893B (en) | 2016-02-05 | 2016-02-05 | Nano silver particles for aquatic products, preparation and application thereof, and bacillus subtilis strain |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105754893A CN105754893A (en) | 2016-07-13 |
CN105754893B true CN105754893B (en) | 2020-03-10 |
Family
ID=56330685
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610081986.9A Expired - Fee Related CN105754893B (en) | 2016-02-05 | 2016-02-05 | Nano silver particles for aquatic products, preparation and application thereof, and bacillus subtilis strain |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105754893B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113828768B (en) * | 2021-09-23 | 2023-08-18 | 尚蒙科技无锡有限公司 | Preparation method and application of modified nano silver or nano silver copper dispersion liquid |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103834596A (en) * | 2014-03-10 | 2014-06-04 | 上海海洋大学 | Bacillus subtilis shou003, anti-vibrio protein and preparation method and applications of bacillus subtilis shou003 and anti-vibrio protein |
-
2016
- 2016-02-05 CN CN201610081986.9A patent/CN105754893B/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103834596A (en) * | 2014-03-10 | 2014-06-04 | 上海海洋大学 | Bacillus subtilis shou003, anti-vibrio protein and preparation method and applications of bacillus subtilis shou003 and anti-vibrio protein |
Non-Patent Citations (1)
Title |
---|
Green synthesis of silver nanoparticles by Bacillus methylotrophicus , and their antimicrobial activity;Chao Wang等;《Artifi cial Cells, Nanomedicine, and Biotechnology》;20150306;1–6 * |
Also Published As
Publication number | Publication date |
---|---|
CN105754893A (en) | 2016-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108676756B (en) | Bei Laisi bacillus and its application as aquatic pathogenic bacterium inhibitor | |
Salvesen et al. | Microbial environments in marine larviculture: impacts of algal growth rates on the bacterial load in six microalgae | |
CN104611251B (en) | One plant has the active lactic acid bacteria of broad-spectrum antibacterial and its application | |
CN113040390B (en) | Probiotic salt-tolerant lactobacillus johnsonii and application thereof in preventing and treating pathogenic bacteria in livestock and poultry aquiculture | |
CN101921710B (en) | Repairing agent for microbes in water bodies of excessive culture zones | |
CN108048352B (en) | Enterococcus faecium XC2 capable of producing antibacterial substances and screening method and application thereof | |
CN114908013B (en) | Shewanella manshurica for producing DDP-IV inhibitor and application thereof | |
CN106148231B (en) | One plant of enterococcus faecalis Y17 and its screening and culturing and application | |
JP2009159955A (en) | Probiotics lactic acid bacterium separated from inside of prawn intestine | |
Silva et al. | Aquatic microbiota diversity in the culture of Nile tilapia (Oreochromis niloticus) using bioflocs or periphyton: virulence factors and biofilm formation | |
CN106497808A (en) | One plant of Lactobacillus salivarius that can be used to produce fermented feed for being isolated from Intestinum Sus domestica road | |
CN114437964B (en) | Bacillus belicus strain and application thereof | |
CN108660097A (en) | The screening and application of one plant of source of fish enterococcus faecium R8 | |
Sunitha et al. | Efficacy of probiotics in water quality and bacterial biochemical characterization of fish ponds | |
CN112538442B (en) | Bacillus licheniformis and application thereof | |
CN107937301B (en) | Bacillus amyloliquefaciens and application thereof in aquaculture | |
CN111733117B (en) | Bacillus marinus for producing antibacterial peptide and fermentation method and application thereof | |
CN105754893B (en) | Nano silver particles for aquatic products, preparation and application thereof, and bacillus subtilis strain | |
KR20190047756A (en) | A composition comprising lactobacillus probiotics and a functional feed additive comprising the same | |
CN113604387B (en) | Salt-tolerant and high-temperature-resistant lactobacillus reuteri and application thereof in prevention and treatment of pathogenic bacteria in livestock and poultry aquaculture | |
CN112592851B (en) | Lactobacillus acidophilus with broad-spectrum antagonistic effect on aquatic pathogenic bacteria and application thereof | |
CN107586329B (en) | Polypeptide separated from pomfret | |
CN115725466A (en) | Staphylococcus equisimilis and application thereof in fish culture | |
CN115637240A (en) | Bacillus belgii and application thereof | |
Ebnetorab et al. | Isolation, biochemical and molecular detection of Bacillus subtilis and Bacillus licheniformis from the digestive system of rainbow trout (Oncorhynchus mykiss) and its inhibitory effect on Aeromonas hydrophila |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20200310 |